Abstract
Background and Aims: Hypertriglyceridaemia is a rare complication of pegaspargase (Oncaspar) treatment, and is associated with a risk of fatal pancreatitis. We describe the case of a patient undergoing treatment for acute leukemia as per the UKALL 2011 protocol regimen C. With this chemotherapy protocol patients do not undergo baseline testing or routine monitoring of lipids.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
